Both research teams found that boosting CAR T cells with high levels of a specific protein can rejuvenate the cells, giving them gene activity similar to that of stem cells and enhancing their ability to fight cancer.
This breakthrough presents a new avenue for engineering therapeutic T cells for cancer patients, offering hope in treating solid tumors challenging to eliminate with current methods like CAR T cell therapy.
[
add
]
[
|
|
...
]